CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Walgreen Boots Alliance - WBA CFD

17.81
1.27%
Market Trading Hours* (UTC) Opens on Monday at 13:30

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.11
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Walgreens Boots Alliance Inc ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 18.04
Open* 17.81
1-Year Change* -50.9%
Day's Range* 17.66 - 17.9
52 wk Range 19.68-37.96
Average Volume (10 days) 21.62M
Average Volume (3 months) 278.02M
Market Cap 19.10B
P/E Ratio 33.32
Shares Outstanding 862.38M
Revenue 142.41B
EPS 0.66
Dividend (Yield %) 4.51467
Beta 0.74
Next Earnings Date Mar 26, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 12, 2024 17.80 0.02 0.11% 17.78 17.92 17.65
Apr 11, 2024 18.04 0.03 0.17% 18.01 18.12 17.70
Apr 10, 2024 17.98 -0.68 -3.64% 18.66 18.71 17.81
Apr 9, 2024 19.13 0.00 0.00% 19.13 19.32 19.01
Apr 8, 2024 19.12 -0.02 -0.10% 19.14 19.42 18.98
Apr 5, 2024 19.07 0.33 1.76% 18.74 19.18 18.57
Apr 4, 2024 18.94 0.41 2.21% 18.53 19.02 18.46
Apr 3, 2024 18.43 -0.19 -1.02% 18.62 19.11 18.43
Apr 2, 2024 18.65 -0.84 -4.31% 19.49 19.56 18.61
Apr 1, 2024 19.48 -2.09 -9.69% 21.57 21.68 19.45
Mar 28, 2024 21.62 0.81 3.89% 20.81 21.98 20.58
Mar 27, 2024 20.95 0.31 1.50% 20.64 21.03 20.51
Mar 26, 2024 20.47 0.28 1.39% 20.19 20.58 20.18
Mar 25, 2024 20.58 -0.04 -0.19% 20.62 21.00 20.51
Mar 22, 2024 20.52 -0.33 -1.58% 20.85 20.99 20.52
Mar 21, 2024 20.75 -0.10 -0.48% 20.85 21.09 20.66
Mar 20, 2024 21.03 0.51 2.49% 20.52 21.09 20.51
Mar 19, 2024 20.64 0.14 0.68% 20.50 20.86 20.49
Mar 18, 2024 20.64 0.08 0.39% 20.56 20.88 20.48
Mar 15, 2024 20.77 0.29 1.42% 20.48 21.03 20.42

Walgreen Boots Alliance Events

Time (UTC) Country Event
Tuesday, June 25, 2024

Time (UTC)

11:00

Country

US

Event

Q3 2024 Walgreens Boots Alliance Inc Earnings Release
Q3 2024 Walgreens Boots Alliance Inc Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Total revenue 139081 132703 132509 121982 120074
Revenue 139081 132703 132509 121982 120074
Cost of Revenue, Total 112049 104437 104442 95905 91915
Gross Profit 27032 28266 28067 26077 28159
Total Operating Expense 144142 130981 130291 121070 115308
Selling/General/Admin. Expenses, Total 23872 24175 23636 21749 22048
Depreciation / Amortization
Interest Expense (Income) - Net Operating -252 -451 1156 -302 -164
Unusual Expense (Income) 8472 2818 1057 3718 1509
Operating Income -5061 1722 2218 912 4766
Interest Income (Expense), Net Non-Operating -452 2173 -499 -602 -495
Net Income Before Taxes -5419 3985 1995 446 4359
Net Income After Taxes -3561 4015 1328 107 3782
Minority Interest 448 271 39 42 26
Equity In Affiliates 33 50 627 31 8
Net Income Before Extra. Items -3080 4336 1994 180 3816
Net Income -3080 4336 2542 457 3982
Income Available to Common Excl. Extra. Items -3080 4337 1994 179 3816
Income Available to Common Incl. Extra. Items -3080 4337 2542 456 3982
Diluted Net Income -3080 4337 2542 456 3982
Diluted Weighted Average Shares 863.2 865.9 866.4 880.3 923.5
Diluted EPS Excluding Extraordinary Items -3.56812 5.00866 2.30148 0.20334 4.13211
Dividends per Share - Common Stock Primary Issue 1.92 1.91 1.87 1.83 1.76
Diluted Normalized EPS 2.8114 7.12403 3.11358 3.0188 5.54981
Other, Net 94 90 276 136 88
Total Extraordinary Items 0 0 548 277 166
Other Operating Expenses, Total 1 2 0
Total Adjustments to Net Income 1 -1
Aug 2023 May 2023 Feb 2023 Nov 2022 Aug 2022
Total revenue 35422 35415 34862 33382 32449
Revenue 35422 35415 34862 33382 32449
Cost of Revenue, Total 28987 28826 27807 26429 26038
Gross Profit 6435 6589 7055 6953 6411
Total Operating Expense 35744 35713 34121 38564 33125
Selling/General/Admin. Expenses, Total 6048 6091 6310 6286 7122
Depreciation / Amortization
Interest Expense (Income) - Net Operating -65 -58 -75 -53 -88
Unusual Expense (Income) 773 853 80 5903 52
Operating Income -322 -298 741 -5182 -676
Interest Income (Expense), Net Non-Operating -77 -123 -141 -110 -111
Other, Net 24 39 7 22 29
Net Income Before Taxes -375 -382 607 -5270 -758
Net Income After Taxes -224 -52 537 -3823 -523
Minority Interest 28 166 159 94 85
Equity In Affiliates 15 4 6 7 21
Net Income Before Extra. Items -181 118 702 -3722 -417
Total Extraordinary Items 0 0
Net Income -181 118 702 -3722 -417
Total Adjustments to Net Income 1 1 1 2
Income Available to Common Excl. Extra. Items -180 118 703 -3721 -415
Income Available to Common Incl. Extra. Items -180 118 703 -3721 -415
Diluted Net Income -180 118 703 -3721 -415
Diluted Weighted Average Shares 863.5 863.8 863.4 863.6 864.5
Diluted EPS Excluding Extraordinary Items -0.20845 0.13661 0.81422 -4.30871 -0.48005
Dividends per Share - Common Stock Primary Issue 0.48 0.48 0.48 0.48 0.4775
Diluted Normalized EPS 0.37342 0.77848 0.89619 0.13426 -0.44095
Other Operating Expenses, Total 1 1 -1 -1 1
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Total Current Assets 15503 16902 15814 18073 18700
Cash and Short Term Investments 739 2472 1193 516 1023
Cash & Equivalents 728 1358 1193 516 1023
Total Receivables, Net 5381 5017 5663 7132 7226
Accounts Receivable - Trade, Net 5381 5017 5663 7132 7226
Total Inventory 8257 8353 8159 9451 9333
Other Current Assets, Total 1126 1060 799 974 1118
Total Assets 96628 90124 81285 87174 67598
Property/Plant/Equipment, Total - Net 33254 32988 34140 35066 13478
Property/Plant/Equipment, Total - Gross 46207 45831 47214 47521 24789
Accumulated Depreciation, Total -12953 -12843 -13073 -12456 -11310
Goodwill, Net 28187 22280 12421 15268 16560
Intangibles, Net 13635 10730 9936 10753 10876
Long Term Investments 3497 5495 6987 7338 6851
Other Long Term Assets, Total 2552 1729 1987 676 1133
Total Current Liabilities 24535 22583 22054 27070 25769
Accounts Payable 12635 11255 11136 14458 14341
Accrued Expenses 10716 10148 9482 8931 5468
Notes Payable/Short Term Debt 0 0 0 1517 2400
Current Port. of LT Debt/Capital Leases 974 1096 1342 2055 3338
Other Current Liabilities, Total 210 84 94 109 222
Total Liabilities 76608 64849 57866 66536 44087
Total Long Term Debt 9064 11514 8649 13223 11098
Long Term Debt 8145 10615 7675 12203 11098
Deferred Income Tax 1318 1442 1850 1498 1785
Minority Interest 8469 5133 721 498 641
Other Liabilities, Total 33222 24177 24592 24247 4794
Total Equity 20020 25275 23419 20638 23511
Common Stock 12 12 12 12 12
Additional Paid-In Capital 10661 10950 10988 10761 10639
Retained Earnings (Accumulated Deficit) 33058 37801 35121 34210 35815
Treasury Stock - Common -20717 -20683 -20593 -20575 -19057
Other Equity, Total -2994 -2806 -2080 -3760 -3901
Total Liabilities & Shareholders’ Equity 96628 90124 81285 87174 67598
Total Common Shares Outstanding 863.674 864.639 865.374 865.604 895.388
Unrealized Gain (Loss) 0 1 -29 -10 3
Capital Lease Obligations 919 899 974 1020
Short Term Investments 11 1114
Aug 2023 May 2023 Feb 2023 Nov 2022 Aug 2022
Total Current Assets 15503 16542 17689 19523 16902
Cash and Short Term Investments 739 970 1840 4232 2472
Cash & Equivalents 728 871 1088 2349 1358
Total Receivables, Net 5381 5843 5730 4853 5017
Accounts Receivable - Trade, Net 5381 5843 5730 4853 5017
Total Inventory 8257 8164 8757 9322 8353
Other Current Assets, Total 1126 1565 1362 1116 1060
Total Assets 96628 98605 100479 92875 90124
Property/Plant/Equipment, Total - Net 33254 33613 33600 32690 32988
Goodwill, Net 28187 28371 28343 22582 22280
Intangibles, Net 13635 13578 13864 10612 10730
Long Term Investments 3497 3527 4069 4426 5495
Other Long Term Assets, Total 2552 2974 2914 3042 1729
Total Current Liabilities 24535 26170 28228 28036 22583
Accounts Payable 12635 12029 12720 12184 11255
Accrued Expenses 10716 10879 11109 11767 10148
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 974 3116 4275 3976 1096
Other Current Liabilities, Total 210 146 124 109 84
Total Liabilities 76608 77542 79287 72299 64849
Total Long Term Debt 9064 9768 9751 8684 11514
Long Term Debt 8145 8841 8820 7789 10615
Capital Lease Obligations 919 927 931 895 899
Deferred Income Tax 1318 1657 2081 1319 1442
Minority Interest 8469 8456 8405 4163 5133
Other Liabilities, Total 33222 31491 30822 30097 24177
Total Equity 20020 21063 21192 20576 25275
Common Stock 12 12 12 12 12
Additional Paid-In Capital 10661 10667 10629 10477 10950
Retained Earnings (Accumulated Deficit) 33058 33654 33952 33664 37801
Treasury Stock - Common -20717 -20731 -20747 -20762 -20683
Unrealized Gain (Loss) 0 -150 -162 1 1
Other Equity, Total -2994 -2389 -2492 -2816 -2806
Total Liabilities & Shareholders’ Equity 96628 98605 100479 92875 90124
Total Common Shares Outstanding 863.674 863.261 862.796 862.342 864.639
Short Term Investments 11 99 752 1883 1114
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 4065 2512 424 3962 5031
Cash From Operating Activities 3898 5555 5485 5595 8263
Cash From Operating Activities 1990 1973 1927 2038 1770
Deferred Taxes -366 233 -43 100 -322
Non-Cash Items -2285 409 2235 234 -154
Cash Taxes Paid 387 336 600 900 600
Cash Interest Paid 420 916 584 676 577
Changes in Working Capital 494 428 942 -739 1938
Cash From Investing Activities -1064 4072 -1297 -2307 -5501
Capital Expenditures -1734 -1379 -1374 -1702 -1367
Other Investing Cash Flow Items, Total 670 5451 77 -605 -4134
Cash From Financing Activities -1499 -9036 -4647 -3047 -5295
Financing Cash Flow Items -1676 -241 -158 74 -98
Total Cash Dividends Paid -1659 -1617 -1747 -1643 -1739
Issuance (Retirement) of Stock, Net -160 -51 -1534 -3986 -5054
Issuance (Retirement) of Debt, Net 1996 -7127 -1208 2508 1596
Foreign Exchange Effects -47 -66 -1 -9 11
Net Change in Cash 1288 525 -460 232 -2522
Feb 2023 Nov 2022 Aug 2022 May 2022 Feb 2022
Net income/Starting Line -3272 -3816 4065 4566 4337
Cash From Operating Activities 1238 493 3898 3812 2184
Cash From Operating Activities 1055 495 1990 1502 1024
Deferred Taxes -1600 -1602 -366 -168 94
Non-Cash Items -1737 -937 -2285 -3052 -2502
Cash Taxes Paid 131 5 387 291 201
Cash Interest Paid 288 160 420 336 211
Changes in Working Capital 6792 6353 494 964 -769
Cash From Investing Activities -3583 1858 -1064 -1262 -2181
Capital Expenditures -1108 -610 -1734 -1241 -870
Other Investing Cash Flow Items, Total -2475 2468 670 -21 -1311
Cash From Financing Activities 1766 -599 -1499 753 769
Financing Cash Flow Items 1409 -68 -1676 -1948 -2129
Total Cash Dividends Paid -829 -415 -1659 -1251 -833
Issuance (Retirement) of Stock, Net -128 -144 -160 -174 -155
Issuance (Retirement) of Debt, Net 1314 28 1996 4126 3886
Foreign Exchange Effects 13 4 -47 -33 -16
Net Change in Cash -566 1756 1288 3270 756

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Walgreen Company profile

What is Walgreen Boots Alliance?

Walgreen Boots Alliance is one of the largest pharmacy chains in the world. It is is split into three business segments: Retail Pharmacy Wholesale, Retail Pharmacy USA and Retail Pharmacy International. The company’s portfolio of retail and business brands includes Walgreens, Duane Reade, Boots and Alliance Healthcare. Among its health and beauty product brands are such household names as No7, Soap & Glory, Liz Earle and Botanics.

 

WBA also has one of the largest global pharmaceutical wholesale and distribution networks. The company is one of the world’s biggest purchasers of prescription drugs and many other health and wellbeing products. Walgreen Boots Alliance says its aim is to “help people across the world lead healthier and happier lives”.

 

Who are the key people at Walgreen Boots Alliance?

Stefano Pessina is Executive Vice Chairman and Chief Executive Officer of Walgreens Boots Alliance. The Italian-born billionaire’s career in the healthcare industry spans four decades. As Executive Deputy Chairman of Alliance UniChem, he led the company's landmark merger with Boots Group PLC in 2006. His voice carries a lot of weight in the sector.

 

WBA has two Co-Chief Operating Officers: Alex Gourlay and Ornella Barra. James A. Skinner serves as Executive Chairman. 

 

What is the modern history of Walgreen Boots Alliance?

Walgreen Boots Alliance was established on December 31, 2014 after Walgreens, the US pharmacy store giant, purchased the 55% of Alliance Boots that it didn’t already own. Alliance Boots was a UK and Switzerland-based health and beauty group formed in 2006 through the merger of high street chain Boots and European pharmacy group Alliance UniChem.

 

What are the latest developments at Walgreen Boots Alliance?

It’s been a time of consolidation in the US healthcare industry, partly prompted by Amazon’s announcement that it is entering the sector to try to lower costs for patients. Some observers think Amazon could use its distribution expertise to undercut existing healthcare firms.

 

Walgreen Boots Alliance has been very active in pursuing potential deals. In September 2017, it agreed to buy 1,932 Rite Aid stores and three distribution centres for almost $4.4 billion in cash. WBA had previously sought to buy all of Rite Aid, but antitrust scrutiny scuppered the proposed deal.

 

In February 2018 it was reported that deal talks between Walgreens Boots Alliance and AmerisourceBergen about an acquisition of the wholesale drug distributor had ended without agreement. Walgreens already has a 26 per cent stake in Amerisource. 

 

Since Walgreen Boots Alliance was founded at the end of 2014, the WBA share price has gone from $76 to a peak of $96 in July 2015 and back down to just $64 in October 2017. On 1 March 2018 the share price stood at $70.20, giving the company a market capitalisation of around $69.5 billion.

 

Our WBA chart tracks the ups and downs of the company’s share price over recent weeks and months.

 

Where does Walgreen Boots Alliance operate?

Walgreens Boots Alliance and the companies in which it has equity method investments have a presence in more than 25 countries around the world, with a total of over 13,000 stores. WBA also has one of the biggest global pharmaceutical wholesale and distribution networks, with over 390 distribution centres delivering to some 230,000 hospitals, health centres, pharmacies and doctors each year in over 20 countries. WBA is headquartered in Deerfield, Illinois.

 

Where is Walgreen Boots Alliance traded?

Walgreen is listed on the NASDAQ stock exchange. Check out Capital.com for the latest WBA chart.

Industry: Drug Retailers (NEC)

108 Wilmot Rd
DEERFIELD
ILLINOIS 60015
US

Income Statement

  • Annual
  • Quarterly

News

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024

How escalating geopolitical tensions are impacting oil markets

The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

13:34, 4 April 2024

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

Higher CPI leaves traders unfazed as US equities continue to build momentum

The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.

12:42, 15 March 2024

People also watch

Gold

2,361.09 Price
+0.670% 1D Chg, %
Long position overnight fee -0.0193%
Short position overnight fee 0.0110%
Overnight fee time 21:00 (UTC)
Spread 0.50

ETH/USD

3,138.09 Price
+7.660% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

BTC/USD

65,260.45 Price
+5.380% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

US100

18,061.80 Price
+0.340% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading